Why Female Sexual Dysfunction Therapy is Lacking
By Kevin Kunzmann The differences between the US Food and Drug Administration (FDA) market for male and female sexual dysfunction therapies are severe, and Maria Sophocles, MD, doesn’t foresee the inequality lessening anytime soon. The medical director of Women’s Healthcare of Princeton told MD Magazine® that a proven and profitable field of male sexual therapies …
Continue reading “Why Female Sexual Dysfunction Therapy is Lacking”
You must be logged in to post a comment.